Stereotactic Body Radiotherapy for Lung Lesions using Multiple Phase ۳D-CT Based on the Analysis of Radiobiological Parameters
Publish place: Iranian Journal of Medical Physics، Vol: 16، Issue: 4
Publish Year: 1398
نوع سند: مقاله ژورنالی
زبان: English
View: 54
This Paper With 10 Page And PDF Format Ready To Download
- Certificate
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_IJMP-16-4_003
تاریخ نمایه سازی: 5 شهریور 1402
Abstract:
Introduction: Planning target volume (PTV) is generated from internal treatment volume (ITV) using four-dimensional computed tomography (۴D-CT) for enhanced therapeutic gain in the stereotactic body radiotherapy for lung lesions (SBRT-Lung). This study aimed to propose a strategy to generate ITV on multiple-phase ۳D-CT and enhance therapeutic gain in SBRT-Lung. Material and Methods: This study was conducted on ۶ peripherally located and ۵ centrally located lung lesions suitable for SBRT. The PTV was delineated based on ۳D-CT datasets acquired at three different phases of respiratory motion. The prescribed dose of ۵۰ Gy in ۵ fractions was delivered using RapidArc technique. The therapeutic-gain was compared based on tumor control probability (TCP) and normal tissue complication probability (NTCP) against a multicenter trial, which uses single-phase ۳D-CT for PTV delineation. The TCP and NTCP were calculated by Poisson’s linear-quadratic and Lyman-Kutcher-Burman models, respectively. Results: Regarding the multicentre trial, the PTVs were maximally reduced to ۴۲% and ۵۷% among the ۶ peripherally and ۵ centrally located lung lesions, respectively. In peripheral lung lesions, TCP was significantly enhanced to ۰.۶% for long-term (>۵years) local control (p <۰.۰۵), and NTCP was significantly reduced in pneumonitis (Grade≥II) of lung (۰.۲%; p <۰.۰۵). In central lung lesions, TCP was insignificantly enhanced; however, NTCPs were maximally reduced for cartilage necrosis in trachea (۳۵%) and myelitis in spinal cord (۱۹%). Conclusion: The proposed strategy reduced the complications for normal tissues and enhanced therapeutic gain. The successful clinical outcomes validated our hypothesis in short-term (۶-۱۲ months), and we are currently testing the long-term efficacy.
Keywords:
Authors
Arun Chairmadurai
Department Of Radiation Oncology, Jaypee Hospital, Sector-۱۲۸, Noida-۲۰۱۳۰۴, U.P. India
Harish Goel
Amity Centre for Radiation Biology, Amity University, Noida-۲۰۱۳۰۴, U.P. India
Sandeep Jain
Department Of Radiation Oncology, Jaypee Hospital, Sector-۱۲۸, Noida-۲۰۱۳۰۴, U.P. India
Pawan Kumar
Department Of Radiation Oncology, Jaypee Hospital, Sector-۱۲۸, Noida-۲۰۱۳۰۴, U.P. India
مراجع و منابع این Paper:
لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :